Mesa Laboratories, Inc. (MLAB)
| Market Cap | 487.25M |
| Revenue (ttm) | 213.69M |
| Net Income (ttm) | -717,000 |
| Shares Out | 5.39M |
| EPS (ttm) | -0.14 |
| PE Ratio | n/a |
| Forward PE | 69.76 |
| Dividend | $0.64 (0.71%) |
| Ex-Dividend Date | Nov 29, 2023 |
| Volume | 46,008 |
| Open | 84.66 |
| Previous Close | 85.37 |
| Day's Range | 84.66 - 91.13 |
| 52-Week Range | 82.86 - 206.36 |
| Beta | 0.83 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2023 |
About MLAB
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to per... [Read more]
Financial Performance
In 2022, MLAB's revenue was $219.08 million, an increase of 18.85% compared to the previous year's $184.34 million. Earnings were $930,000, a decrease of -50.29%.
Financial StatementsNews
Mesa Labs Announces Second Quarter Results
LAKEWOOD, Colo., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, ...
Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform
Lakewood, Colo., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and manufacturing of life science tools and critic...
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quart...
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023
LAKEWOOD, Colo., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately ...
Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions
LAKEWOOD, Colo., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories Inc (Nasdaq: MLAB; “Mesa” or the “Company”), a global leader in the design and manufacturing of life science tools and critical qua...
Mesa Labs Announces First Quarter Results
LAKEWOOD, Colo., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, ...
Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023
LAKEWOOD, Colo., June 21, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2024 at approximately 8:...
Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results
LAKEWOOD, Colo., May 25, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, t...
Mesa Labs Announces Third Quarter Results
LAKEWOOD, Colo., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, ...
Mesa Labs Declares Quarterly Dividend
LAKEWOOD, Colo., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quart...
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023
LAKEWOOD, Colo., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2023 at approximately 8:...
Mesa Labs Acquires Belyntic's Peptide Purification Business
Lakewood, Colorado, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control...
Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director
Appointment is a Key Step in Enhancing Mesa's Corporate Governance Appointment is a Key Step in Enhancing Mesa's Corporate Governance
Mesa Laboratories Appoints Tony Tripeny to its Board of Directors
LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the “Board”), effective June 23, 2022. Ton...
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
LAKEWOOD, Colo., May 31, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q22”) and full year ended March 31, 2022 (“FY22”).
Mesa Labs Closes Acquisition of Agena Bioscience
LAKEWOOD, Colo., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that it has completed the previously announced acquisition of Agena Biosciences, Inc. With this...
Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.
LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical qual...
Mesa Laboratories: Q4 Earnings Insights
Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 53.49% year over year to $1.98, which beat the estimate o...
Mesa Labs Reports Third Quarter Results for FY21
LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (“3Q21”) and nine months ended December 31, 2020.
Mesa Labs Reports Second Quarter Results for FY21
LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020.
Mesa Labs Reports First Quarter Results
LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”).
Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering
Source: Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET
Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
Source: Mesa Laboratories, Inc. - June 9, 2020 8:15 PM ET
Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock
Source: Mesa Laboratories, Inc. – June 8, 2020 4:01 PM ET
Recap: Mesa Laboratories Q4 Earnings
Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results.